In March 2025, the company declared new programs for any direct-to-consumer giving of its Wegovy weight loss drug. The company set up a different pharmacy, identified as NovoCare, which might demand shoppers $499 per month for access to the drug, under fifty percent the expense of the drug via other pharmaceutical distribution networks.[53]Notable